All Comments by

  1. Michael G. Agadjanyan on Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice.
  2. Terrence Town on Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
  3. Suzanne Guenette on Keystone: Death Receptor Ligand—New Role for APP, New Model for AD? PAPER RETRACTED.
  4. George Martin on The Rodent in Old Age
  5. Gang Liu on Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis.
  6. Sanjay Pimplikar on Keystone: Death Receptor Ligand—New Role for APP, New Model for AD? PAPER RETRACTED.
  7. David Cribbs on Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques.
  8. Lon S. Schneider on Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.
  9. Grace Stutzmann on Calcium signaling and neurodegenerative diseases.
  10. Lary Walker on Driving amyloid toxicity in a yeast model by structural changes: a molecular approach.
  11. Takaomi Saido on Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
  12. Jeffrey D. Rothstein on New Gene for ALS: RNA Regulation May Be Common Culprit
  13. Andrea Fuso on Epigenetic changes in Alzheimer's disease: decrements in DNA methylation.
  14. Mary Reid on Keystone: Death Receptor Ligand—New Role for APP, New Model for AD? PAPER RETRACTED.
  15. Chad Dickey on Garbage BAG2 Takes Out the Tau